cimemoxin cimemoxin cimemoxin (inn), or cyclohexylmethylhydrazine, is a hydrazine monoamine oxidase inhibitor (maoi) antidepressant which was never marketed. cimemoxinclinical dataatc codenoneidentifiers iupac name cyclohexylmethylhydrazine cas number3788-16-7 ypubchem cid71824chemspider64848unii584qs921r2chemblchembl2106052comptox dashboard (epa)dtxsid30191314 chemical and physical dataformulac7h16n2molar mass128.219 g·mol−13d model (jsmol)interactive image smiles nncc1ccccc1 inchi inchi=1s/c7h16n2/c8-9-6-7-4-2-1-3-5-7/h7,9h,1-6,8h2key:bdhmbghswfwysp-uhfffaoysa-n synthesis it possesses 50 times the relative activity of iproniazid and 25x nialamide (see patent). synthesis: 3-cyclohexene-1-carbaldehyde (aka 1,2,3,6-tetrahydrobenzaldehyde) is reacted with n-acetylhydrazine to give the hydrazone, which is reduced by catalytic hydrogenation. the acetyl group is removed by acid hydrolysis.